Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Southern California
Study ID
NCT07076147
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
30 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.

Key Dates

Start date
Jun 2, 2025
Status verified
May 2026
Primary completion
Jun 2, 2027
Completion
Jun 2, 2028

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Observational
    Patients complete a questionnaire and have their medical records reviewed on study.

Primary Outcome Measure

Proportion of women who undergo a screening breast MRI within 12 months of genetic test counseling [ Time Frame: Up to 2 years ]

Locations (2)

FacilityCityStateZIPSite coordinators
Los Angeles General Medical CenterLos AngelesCalifornia90033
Jacob Comeaux
[email protected]
323-865-0474
Jacob Comeaux (PRINCIPAL_INVESTIGATOR)
USC / Norris Comprehensive Cancer CenterLos AngelesCalifornia90033
Jacob Comeaux
[email protected]
323-865-0474
Jacob Comeaux (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Los Angeles General Medical Center· Los Angeles, CAUSC / Norris Comprehensive Cancer Center· Los Angeles, CA

Related Studies